Cellbion
₩12,530
0
-₩150-1.18% 06:30 Today
Statistics
Day High
12,990
Day Low
12,290
52W High
42,200
52W Low
11,330
Volume
9,743
Avg. Volume
68,867
Mkt Cap
160.62B
P/E Ratio
-
Dividend Yield
-
Dividend
-
Financials
-317.32%Profit Margin
Unprofitable2.29BRevenue
-7.27BNet Income
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
CellBion Co., Ltd. engages in the research and development of radiopharmaceutical products. Its clinical stage pipeline includes 177Lu-PSMA-DGUL, indicated for prostate cancer radiotherapy, currently under Phase 2 clinical stage; 225Ac-Antibody, indicated for multiple cancer types, currently under pre-clinical stage; 225Ac-DGUL, indicated for prostate cancer radiotherapy, currently under pre-clinical stage; 68Ga-Nota-MSA, indicated for cardiovascular disease diagnosis, currently under Phase 2 clinical stage; 99mTc-MSA-ICG, indicated for lymphoscintigraphy SLN mapping, currently under Phase 1 clinical stage; and 68Ga-NGUL, indicated for prostate cancer diagnosis, currently under Phase 2 clinical stage. It is involved in the development of preclinical stage pipeline comprising 68 Ga-FAP, indicated for solid tumors diagnosis; 225 Ac-FAP, indicated for solid tumors radiotherapy; and peptide-based radioligand therapy and antibody-radionuclide conjugates for undisclosed indications. CellBion Co., Ltd. was founded in 2010 and is headquartered in Seoul, South Korea.
Show more...
CEO
Mr. Kweon Kim Ph.D.
Employees
55
Country
South Korea
ISIN
KR7308430008
Listings
0 Comments
Share your thoughts
FAQ
What is Cellbion stock price today?▼
The current price of 308430.KQ is ₩12,530 KRW — it has decreased by -1.18% in the past 24 hours. Watch Cellbion stock price performance more closely on the chart.
What is Cellbion stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on KOSDAQ exchange Cellbion stocks are traded under the ticker 308430.KQ.
Is Cellbion stock price growing?▼
308430.KQ stock has risen by +2.29% compared to the previous week, the month change is a -15.91% fall, over the last year Cellbion has showed a -55.01% decrease.
What is Cellbion market cap?▼
Today Cellbion has the market capitalization of 160.62B
What is Cellbion revenue for the last year?▼
Cellbion revenue for the last year amounts to 2.29B KRW.
What is Cellbion net income for the last year?▼
308430.KQ net income for the last year is -7.27B KRW.
How many employees does Cellbion have?▼
As of July 27, 2026, the company has 55 employees.
In which sector is Cellbion located?▼
Cellbion operates in the Other sector.
When did Cellbion complete a stock split?▼
Cellbion has not had any recent stock splits.
Where is Cellbion headquartered?▼
Cellbion is headquartered in Seoul, South Korea.